All In Biotech

Drug Trial Radar · NCT06858579

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of DNTH103 In Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 256 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

256

Planned (sponsor's estimate)

Start

Feb 10, 2025

Primary completion

Dec 31, 2028

Study completion Dec 31, 2030

Sponsor

Lead sponsor
Dianthus TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Phase 3 study is to demonstrate the efficacy of claseprubart (DNTH103) as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP).

Conditions

  • Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

  • ClaseprubartDrug

    IV Infusion

  • ClaseprubartDrug

    SC injection

  • PlaceboDrug

    SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part B: Time From First Dose to Relapse as Assessed by the Adjusted Inflammatory Neuropathy Cause and Treatment (INCAT)Time frame: Part B baseline to Part B end of treatment period (up to Week 52)

Locations

201 sites in 31 countries. Site status is shown where the registry gives one.

  • Clinical Study Site

    Birmingham, Alabama · Recruiting

  • Clinical Study Site

    Phoenix, Arizona · Recruiting

  • Clinical Study Site

    Scottsdale, Arizona · Recruiting

  • Clinical Study Site

    Los Angeles, California · Recruiting

  • Clinical Study Site

    San Francisco, California · Recruiting

  • Clinical Study Site

    San Francisco, California · Recruiting

  • Cinical Study Site

    New Haven, Connecticut · Recruiting

  • Clinical Study Site

    Washington D.C., District of Columbia · Recruiting

  • Clinical Study Site

    Maitland, Florida · Recruiting

  • Clinical Study Site

    Tampa, Florida · Recruiting

  • Clinical Study Site

    Honolulu, Hawaii · Recruiting

  • Clinical Study Site

    Chicago, Illinois · Recruiting

  • Clinical Study Site

    Edwardsville, Illinois · Recruiting

  • Clinical Study Site

    Indianapolis, Indiana · Recruiting

  • Clinical Study Site

    Kansas City, Kansas · Recruiting

  • Clinical Study Site

    Burlington, Massachusetts · Recruiting

  • Clinical Study Site

    East Lansing, Michigan · Recruiting

  • Clinical Study Site

    Omaha, Nebraska · Recruiting

  • Cinical Study Site

    Lebanon, New Hampshire · Recruiting

  • Clinical Study Site

    New York, New York · Recruiting

  • Clinical Study Site

    New York, New York · Recruiting

  • Clinical Study Site

    Cincinnati, Ohio · Recruiting

  • Clinical Study Site

    Columbus, Ohio · Recruiting

  • Clinical Study Site

    Portland, Oregon · Recruiting

  • Cinical Study Site

    Nashville, Tennessee · Recruiting

  • Clinical Study Site

    Dallas, Texas · Recruiting

  • Clinical Study Site

    Denton, Texas · Recruiting

  • Cinical Study Site

    Houston, Texas · Recruiting

  • Texas Locations

    Houston, Texas · Recruiting

  • Clinical Study Site

    Round Rock, Texas · Recruiting

  • Clinical Study Site

    Sugar Land, Texas · Recruiting

  • Clinical Study Site

    Seattle, Washington · Recruiting

  • Cinical Study Site #3

    Buenos Aires, Argentina · Recruiting

  • Cinical Study Site #4

    Buenos Aires, Argentina · Recruiting

  • Cinical Study Site

    Buenos Aires, Argentina · Recruiting

  • Clinical Study Site #2

    Buenos Aires, Argentina · Recruiting

  • Clinical Study Site

    Buenos Aires, Argentina · Recruiting

  • Cinical Study Site #2

    San Miguel de Tucumán, Argentina · Recruiting

  • Clinical Study Site

    San Miguel de Tucumán, Argentina · Recruiting

  • Cinical Study Site

    Buenos Aires, Buenos Aires, Argentina · Recruiting

Showing 40 of 201 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.